IL94301A - Process for the preparation of acetic oxophetylazinyl acids, certain new compounds and pharmaceutical preparations containing them - Google Patents
Process for the preparation of acetic oxophetylazinyl acids, certain new compounds and pharmaceutical preparations containing themInfo
- Publication number
- IL94301A IL94301A IL9430190A IL9430190A IL94301A IL 94301 A IL94301 A IL 94301A IL 9430190 A IL9430190 A IL 9430190A IL 9430190 A IL9430190 A IL 9430190A IL 94301 A IL94301 A IL 94301A
- Authority
- IL
- Israel
- Prior art keywords
- alkyl
- hydrogen
- compound
- trifluoromethyl
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL114271A IL114271A (en) | 1989-05-11 | 1990-05-06 | Oxophthalazinic acid derivatives Acetic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/350,997 US4954629A (en) | 1989-05-11 | 1989-05-11 | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
IL94301A0 IL94301A0 (en) | 1991-03-10 |
IL94301A true IL94301A (en) | 1996-01-19 |
Family
ID=23379152
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9430190A IL94301A (en) | 1989-05-11 | 1990-05-06 | Process for the preparation of acetic oxophetylazinyl acids, certain new compounds and pharmaceutical preparations containing them |
IL114271A IL114271A (en) | 1989-05-11 | 1990-05-06 | Oxophthalazinic acid derivatives Acetic acid |
IL11427195A IL114271A0 (en) | 1989-05-11 | 1995-06-22 | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL114271A IL114271A (en) | 1989-05-11 | 1990-05-06 | Oxophthalazinic acid derivatives Acetic acid |
IL11427195A IL114271A0 (en) | 1989-05-11 | 1995-06-22 | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
Country Status (30)
Country | Link |
---|---|
US (1) | US4954629A (sv) |
EP (1) | EP0397350B1 (sv) |
JP (1) | JPH035479A (sv) |
KR (1) | KR920006419B1 (sv) |
CN (1) | CN1025855C (sv) |
AR (1) | AR246968A1 (sv) |
AT (1) | ATE103913T1 (sv) |
AU (2) | AU618898B2 (sv) |
BG (1) | BG50609A3 (sv) |
CA (1) | CA2016504C (sv) |
CZ (1) | CZ281213B6 (sv) |
DD (1) | DD294257A5 (sv) |
DE (1) | DE69007846T2 (sv) |
DK (1) | DK0397350T3 (sv) |
EG (1) | EG19082A (sv) |
ES (1) | ES2063265T3 (sv) |
FI (1) | FI93959C (sv) |
HU (1) | HU212304B (sv) |
IE (1) | IE62591B1 (sv) |
IL (3) | IL94301A (sv) |
MX (2) | MX167455B (sv) |
NO (1) | NO177708C (sv) |
NZ (1) | NZ233597A (sv) |
PH (1) | PH26567A (sv) |
PL (1) | PL164427B1 (sv) |
PT (1) | PT93985B (sv) |
RO (1) | RO107256B1 (sv) |
RU (1) | RU2014333C1 (sv) |
YU (1) | YU91290A (sv) |
ZA (1) | ZA903565B (sv) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4996204A (en) * | 1989-05-11 | 1991-02-26 | Pfizer Inc. | Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors |
IL124236A (en) * | 1997-05-05 | 2003-01-12 | Pfizer | Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor |
EP0982306A3 (en) * | 1998-08-21 | 2000-07-05 | Pfizer Products Inc. | Polymorph of zopolrestat monohydrate |
DK3597650T3 (da) * | 2010-07-16 | 2022-11-21 | Univ Columbia | Aldosereduktasehæmmere og anvendelser deraf |
US8916563B2 (en) | 2010-07-16 | 2014-12-23 | The Trustees Of Columbia University In The City Of New York | Aldose reductase inhibitors and uses thereof |
CN102558184B (zh) * | 2011-12-30 | 2014-07-16 | 西南大学 | 酞嗪类衍生物的合成方法 |
CN102702108A (zh) * | 2012-06-27 | 2012-10-03 | 上海大学 | 1,2-二氢酞嗪类化合物及其合成方法 |
CN102863393A (zh) * | 2012-09-26 | 2013-01-09 | 上海大学 | 1,2-二氢酞嗪类化合物及其合成方法 |
EP4316603A3 (en) | 2016-06-21 | 2024-04-17 | The Trustees of Columbia University in the City of New York | 4-oxo-3,4-dihydrothieno[3,4-d]pyridazine compounds as aldose reductase inhibitors and methods of use thereof |
EP4417260A2 (en) | 2017-07-28 | 2024-08-21 | Applied Therapeutics, Inc. | Compositions and methods for treating galactosemia |
KR20220003529A (ko) | 2019-04-01 | 2022-01-10 | 어플라이드 테라퓨틱스 인크. | 알도스 리덕타제의 억제제 |
AU2020268368A1 (en) | 2019-05-07 | 2022-01-06 | Ucl Business Ltd | Treatment and detection of inherited neuropathies and associated disorders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
DE3337859A1 (de) * | 1983-01-21 | 1984-07-26 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von benzthiazolen |
CA1299178C (en) * | 1985-11-07 | 1992-04-21 | Banavara Lakshmana Mylari | Heterocyclic oxophtalazinyl acetic acids |
DE3684410D1 (de) * | 1985-11-07 | 1992-04-23 | Pfizer | Heterocyclische oxophthalazinylessigsaeure. |
JPH0676391B2 (ja) * | 1987-06-09 | 1994-09-28 | フアイザー・インコーポレイテツド | ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法 |
EP0322153A3 (en) * | 1987-12-21 | 1990-08-16 | Pfizer Inc. | Heterocyclic oxophtalazinyl acetic acids |
WO1989006651A1 (en) * | 1988-01-19 | 1989-07-27 | Pfizer Inc. | 1h-indazole-3-acetic acids as aldose reductase inhibitors |
US4996204A (en) * | 1989-05-11 | 1991-02-26 | Pfizer Inc. | Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors |
-
1989
- 1989-05-11 US US07/350,997 patent/US4954629A/en not_active Expired - Lifetime
-
1990
- 1990-04-25 ES ES90304441T patent/ES2063265T3/es not_active Expired - Lifetime
- 1990-04-25 DK DK90304441.0T patent/DK0397350T3/da active
- 1990-04-25 EP EP90304441A patent/EP0397350B1/en not_active Expired - Lifetime
- 1990-04-25 AT AT90304441T patent/ATE103913T1/de not_active IP Right Cessation
- 1990-04-25 DE DE69007846T patent/DE69007846T2/de not_active Expired - Fee Related
- 1990-05-02 RO RO144965A patent/RO107256B1/ro unknown
- 1990-05-04 IE IE162690A patent/IE62591B1/en not_active IP Right Cessation
- 1990-05-06 IL IL9430190A patent/IL94301A/en not_active IP Right Cessation
- 1990-05-06 IL IL114271A patent/IL114271A/en not_active IP Right Cessation
- 1990-05-08 CZ CS902278A patent/CZ281213B6/cs not_active IP Right Cessation
- 1990-05-08 NZ NZ233597A patent/NZ233597A/en unknown
- 1990-05-09 PT PT93985A patent/PT93985B/pt not_active IP Right Cessation
- 1990-05-09 PL PL90285113A patent/PL164427B1/pl unknown
- 1990-05-10 RU SU904743977A patent/RU2014333C1/ru active
- 1990-05-10 EG EG27690A patent/EG19082A/xx active
- 1990-05-10 KR KR1019900006579A patent/KR920006419B1/ko not_active IP Right Cessation
- 1990-05-10 AU AU54906/90A patent/AU618898B2/en not_active Ceased
- 1990-05-10 NO NO902071A patent/NO177708C/no not_active IP Right Cessation
- 1990-05-10 CA CA002016504A patent/CA2016504C/en not_active Expired - Fee Related
- 1990-05-10 BG BG091982A patent/BG50609A3/xx unknown
- 1990-05-10 ZA ZA903565A patent/ZA903565B/xx unknown
- 1990-05-10 FI FI902333A patent/FI93959C/sv not_active IP Right Cessation
- 1990-05-10 YU YU91290A patent/YU91290A/sh unknown
- 1990-05-10 DD DD90340590A patent/DD294257A5/de not_active IP Right Cessation
- 1990-05-10 CN CN90102797A patent/CN1025855C/zh not_active Expired - Fee Related
- 1990-05-10 HU HU902995A patent/HU212304B/hu not_active IP Right Cessation
- 1990-05-10 AR AR90316824A patent/AR246968A1/es active
- 1990-05-11 JP JP2122862A patent/JPH035479A/ja active Granted
- 1990-05-11 MX MX020672A patent/MX167455B/es unknown
- 1990-05-11 PH PH40512A patent/PH26567A/en unknown
-
1991
- 1991-10-28 AU AU86806/91A patent/AU626225B2/en not_active Ceased
-
1992
- 1992-12-31 MX MX9207687A patent/MX9207687A/es not_active IP Right Cessation
-
1995
- 1995-06-22 IL IL11427195A patent/IL114271A0/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4690930A (en) | Pyrazolo[4,3-c]quinoline-3-one and imidazo[4,3-c]cinnolin-3-one derivatives and their use as psychotropic agents | |
NZ251804A (en) | Aromatic quinazoline derivatives and medicaments | |
CA2562244A1 (en) | Cyclic compounds | |
US10087144B2 (en) | Agents for use in the treatment of cardiovascular and inflammatory diseases structurally based on 4(1 H)-quinolone | |
IL94301A (en) | Process for the preparation of acetic oxophetylazinyl acids, certain new compounds and pharmaceutical preparations containing them | |
HU197572B (en) | Process for production of derivatives of imidozopiridin and medical compositions containing them as active substance | |
IE83508B1 (en) | Quinoxalines, processes for their preparation, and their use | |
IL108636A (en) | Multi-Transformed History of 2-Amino-Thiazole, Preparation and Pharmaceutical Preparations Containing Them | |
CA1306747C (en) | Process for the preparation of new heterocyclic derivatives which can be used especially as aldose reductase inhibitors | |
JPH06116264A (ja) | ジヒドロイミダゾピロロピリジン類及びそれらの誘導体 | |
IE66029B1 (en) | Pyridazinone derivatives | |
IE904508A1 (en) | Substituted oxophthalazinyl acetic acids and analogs thereof | |
EP0053789B1 (en) | 2-pyridinecarboxamide derivative, process for preparing same and pharmaceutical composition, useful as an anti-allergic agent | |
US5171862A (en) | Process and indazole intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof | |
US5182391A (en) | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof | |
US5075442A (en) | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof | |
Marsham et al. | Quinazoline antifolate thymidylate synthase inhibitors: bridge modifications and conformationally restricted analogs in the C2-methyl series | |
US4307092A (en) | 1-Oxo-5H-pyrimido[2,1-C]benzoxazine-2-carboxylic acid esters | |
SE446532B (sv) | Bensimidazol- och bensimidazolidin-derivat | |
Nesi et al. | A new spiro annellation reaction in the isoxazole series: applications and limits. Part 2. Reactivity of ethyl 4-nitro-3-phenylisoxazole-5-carboxylate with nitrogen binucleophiles | |
CA2100164A1 (en) | 2,4-dioxo-pyrido[2,3-d]pyrimidine-3-acetic acids and esters and salts thereof | |
FR2669928A1 (fr) | Nouveaux derives de pyrimidine antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant. | |
JPS61233688A (ja) | ベンゼン縮合複素環化合物 | |
NO159490B (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive beta-karbolin-3-karboksylsyrederivater. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |